Delta Manufacturing Limited Reports Q1 FY2026 Loss, Reappoints Dr. Ram H. Shroff as Managing Director

2 min read     Updated on 12 Aug 2025, 10:07 PM
scanx
Reviewed by
Naman SharmaScanX News Team
whatsapptwittershare
Overview

Delta Manufacturing Limited reported a standalone loss of ₹154.62 lakhs for Q1 FY2026, improving from ₹258.03 lakhs loss in Q1 FY2025. Revenue decreased to ₹1,431.67 lakhs from ₹1,578.31 lakhs. The company's Hard Ferrites segment incurred a loss, while the Textile segment was profitable. The Board approved Dr. Ram H. Shroff's reappointment as Managing Director for three years, subject to shareholder approval. The 43rd Annual General Meeting is scheduled for September 29, 2025.

16562245

*this image is generated using AI for illustrative purposes only.

Delta Manufacturing Limited , a leading player in the manufacturing sector, has announced its financial results for the first quarter of fiscal year 2026, along with key management changes and upcoming corporate events.

Financial Performance

For the quarter ended June 30, 2025, Delta Manufacturing reported a standalone loss of ₹154.62 lakhs, showing an improvement from the loss of ₹258.03 lakhs in the same quarter of the previous year. The company's revenue from operations declined to ₹1,431.67 lakhs from ₹1,578.31 lakhs year-over-year.

The consolidated financial results paint a similar picture:

Particulars (in ₹ lakhs) Q1 FY2026 Q1 FY2025
Revenue from operations 1,431.67 1,578.31
Total income 1,461.16 1,589.29
Total Expenses 1,622.29 1,854.30
Loss before tax (224.93) (265.01)
Loss after tax (221.76) (264.17)

Segment Performance

The company operates in two main segments:

  1. Hard Ferrites: This segment reported revenue of ₹26.85 lakhs but incurred a loss of ₹149.82 lakhs.
  2. Textile: The textile segment performed better with revenue of ₹1,404.82 lakhs and a profit of ₹31.62 lakhs.

Management Changes

In a significant development, the Board of Directors has approved the re-appointment of Dr. Ram H. Shroff as Managing Director and Executive Vice Chairman of the company. The re-appointment is for a period of three years, from October 1, 2025, to September 30, 2028, subject to shareholder approval at the upcoming Annual General Meeting.

Dr. Shroff, a qualified medical doctor with over 17 years of experience at Charak Pharma, has been instrumental in Delta Manufacturing's growth since joining as Managing Director in 2012. Under his leadership, the company has seen significant operational expansions, including increasing the soft ferrite facility capacity from 7 MT/month to 140 MT/month.

Corporate Updates

The company has scheduled its 43rd Annual General Meeting for September 29, 2025, to be held through Video Conferencing (VC) or Other Audio-Visual Means (OAVM).

Outlook

While the company continues to face challenges, as evidenced by the quarterly loss, the improvement in financial performance compared to the previous year and the re-appointment of Dr. Shroff indicate a focus on long-term stability and growth. The company's diverse operations in hard ferrites and textiles, along with its strategic initiatives, position it to navigate the current economic landscape.

Investors and stakeholders will be watching closely to see how Delta Manufacturing's strategies unfold in the coming quarters, particularly in light of the global economic uncertainties and the company's efforts to strengthen its market position.

Historical Stock Returns for Delta Manufacturing

1 Day5 Days1 Month6 Months1 Year5 Years
+3.67%+2.04%+8.90%+54.87%-10.18%+358.26%
Delta Manufacturing
View in Depthredirect
like18
dislike
Explore Other Articles
89.36
+3.16
(+3.67%)